Navigation Links
ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs
Date:2/20/2009

V inhibitors following the entry of IQP-0410 to Phase 1 human clinical trials in early 2009. These studies included ImQuest coauthors Robert W. Buckheit, Jr. (Executive Vice President), Robert Buckheit, III, Christa Buckheit, and Karen M. Watson.

Karen M. Watson, M.S. (Director, Topical Microbicide Research & Development) presented critical new information regarding the ongoing development of IQP-0528 as a vaginally applied agent to prevent the sexual transmission of HIV. Ms. Watson was also an invited participant in a themed discussion entitled "Novel Microbicide Gels and Rings". ImQuest is currently working on the development of IQP-0528 as both a gel and an intravaginal ring product in combination with other highly active microbicide products. These studies included ImQuest coauthors Robert W. Buckheit, Jr., Christa Buckheit, and ImQuest collaborators from The University of Utah.

"These results further define the therapeutic and preventative niche which the pyrimidinediones may fill and their development may not only prevent the transmission of HIV among sexual partners, but may also possess important therapeutic benefits in the context of the inhibition of highly drug resistant virus strains," said Dr. Buckheit. "We are excited to see IQP-0410 enter human clinical trials in 2009."

ImQuest Life Sciences, a privately held U.S. company located in Frederick, Maryland specializes in the preclinical and clinical development of novel compounds for the treatment of infectious disease and cancer. ImQuest BioSciences, also located in Frederick, Maryland, is a leading provider of anti-infective and anti-cancer drug and vaccine development services to the biotechnology and pharmaceutical industry.

    For further information regarding this press release please contact:
    Robert W. Buckheit, Jr., Ph.D.
    Executive Vice President and Chief Scientific Officer
 
'/>"/>
SOURCE ImQuest Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
2. ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
3. ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections
4. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
5. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
6. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
7. Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
8. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
9. CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2007
10. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
11. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Francisco, CA (PRWEB) July 24, 2014 ... to be semi-finalists in Livestrong’s Big C Competition. Out ... Health are each headed to the semi-final round. In ... Livestrong’s exclusive three-month accelerator program, complete with mentoring from ... , As part of the angelMD commitment to ...
(Date:7/24/2014)... 2014  Neogen Corporation (Nasdaq: NEOG ) ... potential revenue from new rodenticide research are premature. In ... on July 22, 2014, Neogen,s CEO commented about several ... "It was my intent Tuesday at our ... a new type of rodenticide, but certainly not to ...
(Date:7/24/2014)... 1000 balances – 4 steps – One Recommendation: ... and expertly narrows down the mass of product choices ... terminals. , First, select the working environment, then ... instead) and define the accuracy – it’s really that ... the list to models that fit best with the ...
(Date:7/24/2014)... Draper University, a top program ... announce that for 6 weeks this summer, 39 ... on the Draper University campus in the heart ... focused on entrepreneurship, building real-world skills, and “learning ... its sixth cohort, continues to refresh its curriculum ...
Breaking Biology Technology:3 angelMD Startups Make Livestrong Big C Semi-finals 2Neogen comments on SenesTech 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3
... the United States Patent and Trademark Office might ... Foundation expects the office to review its controversial stem ... for WARF, said the foundation remains confident in the validity ... is likely. , ,"Ninety-five percent of the requests to ...
... high-stakes game of citywide wireless Internet, do deep pockets trump local ... example, the answer might be yes. Earlier this year, Milwaukee was ... in the nation. City officials hoped to have some areas of ... now it looks as though wireless hot spots will have to ...
... Wis. - Wisconsin can create a dynamic, creative ... and shedding its "welfare state" mentality, the leader of ... executives. , ,John Jazwiec, who earlier this year made ... what he acknowledged were radical thoughts before an Economic ...
Cached Biology Technology:WARF expects review of stem cell patents 2WARF expects review of stem cell patents 3Milwaukee runs out of patience with wireless Internet provider 2Milwaukee runs out of patience with wireless Internet provider 3RedPrairie exec calls for 50 percent tax cut 2RedPrairie exec calls for 50 percent tax cut 3RedPrairie exec calls for 50 percent tax cut 4
(Date:7/25/2014)... between autism and disrupted brain development is an ... and is largely unknown. However, thanks to funding ... George Washington University (GW) researcher Anthony-Samuel LaMantia, Ph.D. ... in-depth answers to these key questions in the ... of pharmacology and physiology at the GW School ...
(Date:7/25/2014)... biomedical engineering at the University of Houston, has ... artificial organ development., "Introduction to Tissue Engineering: Applications ... into the field of artificial organ development. Metin ... at UH, served as a series editor on ... other published books on the subject of growing ...
(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2University of Houston researcher publishes textbook on tissue engineering 2
... A drug used to treat asthma has been shown ... peptide in the brain that is implicated in the ... University,s School of Medicine. The researchers published their ... an AD Transgenic Mouse Model," in the American ...
... Association for Cancer Research will recognize leaders in the ... in Cancer Research Awards. The 36 recipients will be ... April 2-6. The Minority-Serving Institution Faculty Scholars in ... working at the level of assistant professor or above ...
... virus (HIV), the cause of AIDS, makes use of ... into the host-cell genome, according to a new study ... Cancer Center Arthur G. James Cancer Hospital and ... prevents the virus from completing this critical step in ...
Cached Biology News:Asthma drug could help control or treat Alzheimer's disease 2AACR congratulates recipients of minority-serving institution in cancer research awards 2AACR congratulates recipients of minority-serving institution in cancer research awards 3AACR congratulates recipients of minority-serving institution in cancer research awards 4AACR congratulates recipients of minority-serving institution in cancer research awards 5AACR congratulates recipients of minority-serving institution in cancer research awards 6AACR congratulates recipients of minority-serving institution in cancer research awards 7HIV integration requires use of a host DNA-repair pathway 2
capacity 250 mL...
... This CLS number is ... created to easily match ... showing no availability yet, ... old Sigma-Aldrich number (Z35,347-7) ...
Certified by the Biological Stain Commission. For staining fresh peripheral blood smears and blood parasites....
... Aminopropylsilane is perhaps the ... chemistry for microarray experiments. ... for Microarrays provide a ... for printing PCR products ...
Biology Products: